Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 99

1.

Dichloroacetate Affects Mitochondrial Function and Stemness-Associated Properties in Pancreatic Cancer Cell Lines.

Tataranni T, Agriesti F, Pacelli C, Ruggieri V, Laurenzana I, Mazzoccoli C, Sala GD, Panebianco C, Pazienza V, Capitanio N, Piccoli C.

Cells. 2019 May 18;8(5). pii: E478. doi: 10.3390/cells8050478.

2.

Body site-dependent variations of microbiota in pancreatic cancer pathophysiology.

Panebianco C, Pazienza V.

Crit Rev Clin Lab Sci. 2019 Jun;56(4):260-273. doi: 10.1080/10408363.2019.1615407. Epub 2019 Jun 6.

PMID:
31060399
3.

Impact of Different Types of Diet on Gut Microbiota Profiles and Cancer Prevention and Treatment.

Klement RJ, Pazienza V.

Medicina (Kaunas). 2019 Mar 29;55(4). pii: E84. doi: 10.3390/medicina55040084. Review.

4.

High Levels of Prebiotic Resistant Starch in Diet Modulate Gene Expression and Metabolomic Profile in Pancreatic Cancer Xenograft Mice.

Panebianco C, Villani A, Pazienza V.

Nutrients. 2019 Mar 27;11(4). pii: E709. doi: 10.3390/nu11040709.

5.

Germline BRCA2 K3326X and CHEK2 I157T mutations increase risk for sporadic pancreatic ductal adenocarcinoma.

Obazee O, Archibugi L, Andriulli A, Soucek P, Małecka-Panas E, Ivanauskas A, Johnson T, Gazouli M, Pausch T, Lawlor RT, Cavestro GM, Milanetto AC, Di Leo M, Pasquali C, Hegyi P, Szentesi A, Radu CE, Gheorghe C, Theodoropoulos GE, Bergmann F, Brenner H, Vodickova L, Katzke V, Campa D, Strobel O, Kaiser J, Pezzilli R, Federici F, Mohelnikova-Duchonova B, Boggi U, Lemstrova R, Johansen JS, Bojesen SE, Chen I, Jensen BV, Capurso G, Pazienza V, Dervenis C, Sperti C, Mambrini A, Hackert T, Kaaks R, Basso D, Talar-Wojnarowska R, Maiello E, Izbicki JR, Cuk K, Saum KU, Cantore M, Kupcinskas J, Palmieri O, Delle Fave G, Landi S, Salvia R, Fogar P, Vashist YK, Scarpa A, Vodicka P, Tjaden C, Iskierka-Jazdzewska E, Canzian F.

Int J Cancer. 2019 Aug 1;145(3):686-693. doi: 10.1002/ijc.32127. Epub 2019 Feb 7.

PMID:
30672594
6.

Probiotic Bifidobacterium lactis, anti-oxidant vitamin E/C and anti-inflammatory dha attenuate lung inflammation due to pm2.5 exposure in mice.

Panebianco C, Eddine FBN, Forlani G, Palmieri G, Tatangelo L, Villani A, Xu L, Accolla R, Pazienza V.

Benef Microbes. 2019 Feb 8;10(1):69-75. doi: 10.3920/BM2018.0060. Epub 2018 Dec 10.

PMID:
30525952
7.

Analysis of Gut Microbiota in Rheumatoid Arthritis Patients: Disease-Related Dysbiosis and Modifications Induced by Etanercept.

Picchianti-Diamanti A, Panebianco C, Salemi S, Sorgi ML, Di Rosa R, Tropea A, Sgrulletti M, Salerno G, Terracciano F, D'Amelio R, Laganà B, Pazienza V.

Int J Mol Sci. 2018 Sep 27;19(10). pii: E2938. doi: 10.3390/ijms19102938.

8.

Histone variant macroH2A1 rewires carbohydrate and lipid metabolism of hepatocellular carcinoma cells towards cancer stem cells.

Lo Re O, Douet J, Buschbeck M, Fusilli C, Pazienza V, Panebianco C, Castracani CC, Mazza T, Li Volti G, Vinciguerra M.

Epigenetics. 2018;13(8):829-845. doi: 10.1080/15592294.2018.1514239. Epub 2018 Sep 29.

PMID:
30165787
9.

Pharmacomicrobiomics: exploiting the drug-microbiota interactions in anticancer therapies.

Panebianco C, Andriulli A, Pazienza V.

Microbiome. 2018 May 22;6(1):92. doi: 10.1186/s40168-018-0483-7. Review.

10.

Exploring the microbiota to better understand gastrointestinal cancers physiology.

Panebianco C, Potenza A, Andriulli A, Pazienza V.

Clin Chem Lab Med. 2018 Aug 28;56(9):1400-1412. doi: 10.1515/cclm-2017-1163. Review.

11.

Influence of gemcitabine chemotherapy on the microbiota of pancreatic cancer xenografted mice.

Panebianco C, Adamberg K, Jaagura M, Copetti M, Fontana A, Adamberg S, Kolk K, Vilu R, Andriulli A, Pazienza V.

Cancer Chemother Pharmacol. 2018 Apr;81(4):773-782. doi: 10.1007/s00280-018-3549-0. Epub 2018 Feb 22.

PMID:
29473096
12.

MicroRNA co-expression networks exhibit increased complexity in pancreatic ductal compared to Vater's papilla adenocarcinoma.

Mazza T, Copetti M, Capocefalo D, Fusilli C, Biagini T, Carella M, De Bonis A, Mastrodonato N, Piepoli A, Pazienza V, Maiello E, di Mola FF, di Sebastiano P, Andriulli A, Tavano F.

Oncotarget. 2017 Oct 31;8(62):105320-105339. doi: 10.18632/oncotarget.22184. eCollection 2017 Dec 1.

13.

Fasting and engineered diets as powerful tool in the medical practice: an old approach in the new era.

Panebianco C, Potenza A, Pazienza V.

Ann Transl Med. 2017 Nov;5(21):429. doi: 10.21037/atm.2017.08.34. No abstract available.

14.

Gut Dysbiosis and Adaptive Immune Response in Diet-induced Obesity vs. Systemic Inflammation.

Pindjakova J, Sartini C, Lo Re O, Rappa F, Coupe B, Lelouvier B, Pazienza V, Vinciguerra M.

Front Microbiol. 2017 Jun 22;8:1157. doi: 10.3389/fmicb.2017.01157. eCollection 2017.

15.

Cancer sniffer dogs: how can we translate this peculiarity in laboratory medicine? Results of a pilot study on gastrointestinal cancers.

Panebianco C, Kelman E, Vene K, Gioffreda D, Tavano F, Vilu R, Terracciano F, Pata I, Adamberg K, Andriulli A, Pazienza V.

Clin Chem Lab Med. 2017 Nov 27;56(1):138-146. doi: 10.1515/cclm-2016-1158.

PMID:
28590915
16.

Rewiring carbohydrate catabolism differentially affects survival of pancreatic cancer cell lines with diverse metabolic profiles.

Tataranni T, Agriesti F, Ruggieri V, Mazzoccoli C, Simeon V, Laurenzana I, Scrima R, Pazienza V, Capitanio N, Piccoli C.

Oncotarget. 2017 Jun 20;8(25):41265-41281. doi: 10.18632/oncotarget.17172.

17.

Fasting inhibits hepatic stellate cells activation and potentiates anti-cancer activity of Sorafenib in hepatocellular cancer cells.

Lo Re O, Panebianco C, Porto S, Cervi C, Rappa F, Di Biase S, Caraglia M, Pazienza V, Vinciguerra M.

J Cell Physiol. 2018 Feb;233(2):1202-1212. doi: 10.1002/jcp.25987. Epub 2017 Jul 11.

PMID:
28471474
18.

Engineered Resistant-Starch (ERS) Diet Shapes Colon Microbiota Profile in Parallel with the Retardation of Tumor Growth in In Vitro and In Vivo Pancreatic Cancer Models.

Panebianco C, Adamberg K, Adamberg S, Saracino C, Jaagura M, Kolk K, Di Chio AG, Graziano P, Vilu R, Pazienza V.

Nutrients. 2017 Mar 27;9(4). pii: E331. doi: 10.3390/nu9040331.

19.

SLC22A3 polymorphisms do not modify pancreatic cancer risk, but may influence overall patient survival.

Mohelnikova-Duchonova B, Strouhal O, Hughes DJ, Holcatova I, Oliverius M, Kala Z, Campa D, Rizzato C, Canzian F, Pezzilli R, Talar-Wojnarowska R, Malecka-Panas E, Sperti C, Federico Zambon C, Pedrazzoli S, Fogar P, Milanetto AC, Capurso G, Delle Fave G, Valente R, Gazouli M, Malleo G, Teresa Lawlor R, Strobel O, Hackert T, Giese N, Vodicka P, Vodickova L, Landi S, Tavano F, Gioffreda D, Piepoli A, Pazienza V, Mambrini A, Pedata M, Cantore M, Bambi F, Ermini S, Funel N, Lemstrova R, Soucek P.

Sci Rep. 2017 Mar 8;7:43812. doi: 10.1038/srep43812.

20.

Histone macroH2A1.2 promotes metabolic health and leanness by inhibiting adipogenesis.

Pazienza V, Panebianco C, Rappa F, Memoli D, Borghesan M, Cannito S, Oji A, Mazza G, Tamburrino D, Fusai G, Barone R, Bolasco G, Villarroya F, Villarroya J, Hatsuzawa K, Cappello F, Tarallo R, Nakanishi T, Vinciguerra M.

Epigenetics Chromatin. 2016 Oct 25;9:45. eCollection 2016.

21.

Senescence in hepatic stellate cells as a mechanism of liver fibrosis reversal: a putative synergy between retinoic acid and PPAR-gamma signalings.

Panebianco C, Oben JA, Vinciguerra M, Pazienza V.

Clin Exp Med. 2017 Aug;17(3):269-280. doi: 10.1007/s10238-016-0438-x. Epub 2016 Sep 21. Review.

PMID:
27655446
22.

Efficacy and epigenetic interactions of novel DNA hypomethylating agent guadecitabine (SGI-110) in preclinical models of hepatocellular carcinoma.

Jueliger S, Lyons J, Cannito S, Pata I, Pata P, Shkolnaya M, Lo Re O, Peyrou M, Villarroya F, Pazienza V, Rappa F, Cappello F, Azab M, Taverna P, Vinciguerra M.

Epigenetics. 2016 Oct 2;11(10):709-720. doi: 10.1080/15592294.2016.1214781. Epub 2016 Sep 20.

23.

Functional single nucleotide polymorphisms within the cyclin-dependent kinase inhibitor 2A/2B region affect pancreatic cancer risk.

Campa D, Pastore M, Gentiluomo M, Talar-Wojnarowska R, Kupcinskas J, Malecka-Panas E, Neoptolemos JP, Niesen W, Vodicka P, Delle Fave G, Bueno-de-Mesquita HB, Gazouli M, Pacetti P, Di Leo M, Ito H, Klüter H, Soucek P, Corbo V, Yamao K, Hosono S, Kaaks R, Vashist Y, Gioffreda D, Strobel O, Shimizu Y, Dijk F, Andriulli A, Ivanauskas A, Bugert P, Tavano F, Vodickova L, Zambon CF, Lovecek M, Landi S, Key TJ, Boggi U, Pezzilli R, Jamroziak K, Mohelnikova-Duchonova B, Mambrini A, Bambi F, Busch O, Pazienza V, Valente R, Theodoropoulos GE, Hackert T, Capurso G, Cavestro GM, Pasquali C, Basso D, Sperti C, Matsuo K, Büchler M, Khaw KT, Izbicki J, Costello E, Katzke V, Michalski C, Stepien A, Rizzato C, Canzian F.

Oncotarget. 2016 Aug 30;7(35):57011-57020. doi: 10.18632/oncotarget.10935.

24.

Development of a metabolites risk score for one-year mortality risk prediction in pancreatic adenocarcinoma patients.

Fontana A, Copetti M, Di Gangi IM, Mazza T, Tavano F, Gioffreda D, Mattivi F, Andriulli A, Vrhovsek U, Pazienza V.

Oncotarget. 2016 Feb 23;7(8):8968-78. doi: 10.18632/oncotarget.7108.

25.

DNA Hypomethylation and Histone Variant macroH2A1 Synergistically Attenuate Chemotherapy-Induced Senescence to Promote Hepatocellular Carcinoma Progression.

Borghesan M, Fusilli C, Rappa F, Panebianco C, Rizzo G, Oben JA, Mazzoccoli G, Faulkes C, Pata I, Agodi A, Rezaee F, Minogue S, Warren A, Peterson A, Sedivy JM, Douet J, Buschbeck M, Cappello F, Mazza T, Pazienza V, Vinciguerra M.

Cancer Res. 2016 Feb 1;76(3):594-606. doi: 10.1158/0008-5472.CAN-15-1336. Epub 2016 Jan 15.

26.

Deregulated expression of cryptochrome genes in human colorectal cancer.

Mazzoccoli G, Colangelo T, Panza A, Rubino R, De Cata A, Tiberio C, Valvano MR, Pazienza V, Merla G, Augello B, Trombetta D, Storlazzi CT, Macchia G, Gentile A, Tavano F, Vinciguerra M, Bisceglia G, Rosato V, Colantuoni V, Sabatino L, Piepoli A.

Mol Cancer. 2016 Jan 15;15:6. doi: 10.1186/s12943-016-0492-8.

27.

Metabolomic profile in pancreatic cancer patients: a consensus-based approach to identify highly discriminating metabolites.

Di Gangi IM, Mazza T, Fontana A, Copetti M, Fusilli C, Ippolito A, Mattivi F, Latiano A, Andriulli A, Vrhovsek U, Pazienza V.

Oncotarget. 2016 Feb 2;7(5):5815-29. doi: 10.18632/oncotarget.6808.

28.

Clock genes-dependent acetylation of complex I sets rhythmic activity of mitochondrial OxPhos.

Cela O, Scrima R, Pazienza V, Merla G, Benegiamo G, Augello B, Fugetto S, Menga M, Rubino R, Fuhr L, Relógio A, Piccoli C, Mazzoccoli G, Capitanio N.

Biochim Biophys Acta. 2016 Apr;1863(4):596-606. doi: 10.1016/j.bbamcr.2015.12.018. Epub 2015 Dec 28.

29.

Functional Impact of Autophagy-Related Genes on the Homeostasis and Dynamics of Pancreatic Cancer Cell Lines.

Mazza T, Fusilli C, Saracino C, Mazzoccoli G, Tavano F, Vinciguerra M, Pazienza V.

IEEE/ACM Trans Comput Biol Bioinform. 2015 May-Jun;12(3):667-78. doi: 10.1109/TCBB.2014.2371824.

PMID:
26357277
30.

Age-related obesity and type 2 diabetes dysregulate neuronal associated genes and proteins in humans.

Rahimi M, Vinciguerra M, Daghighi M, Özcan B, Akbarkhanzadeh V, Sheedfar F, Amini M, Mazza T, Pazienza V, Motazacker MM, Mahmoudi M, De Rooij FW, Sijbrands E, Peppelenbosch MP, Rezaee F.

Oncotarget. 2015 Oct 6;6(30):29818-32. doi: 10.18632/oncotarget.4904.

31.

Fasting cycles potentiate the efficacy of gemcitabine treatment in in vitro and in vivo pancreatic cancer models.

D'Aronzo M, Vinciguerra M, Mazza T, Panebianco C, Saracino C, Pereira SP, Graziano P, Pazienza V.

Oncotarget. 2015 Jul 30;6(21):18545-57.

32.

Hepatitis viruses exploitation of host DNA methyltransferases functions.

Pazienza V, Panebianco C, Andriulli A.

Clin Exp Med. 2016 Aug;16(3):265-72. doi: 10.1007/s10238-015-0372-3. Epub 2015 Jul 7. Review.

PMID:
26148656
33.

SIRT1 and circadian gene expression in pancreatic ductal adenocarcinoma: Effect of starvation.

Tavano F, Pazienza V, Fontana A, Burbaci FP, Panebianco C, Saracino C, Lombardi L, De Bonis A, di Mola FF, di Sebastiano P, Piepoli A, Vinciguerra M, Fracavilla M, Giuliani F, Rubino R, Andriulli A, Mazzoccoli G.

Chronobiol Int. 2015 May;32(4):497-512. doi: 10.3109/07420528.2014.1003351. Epub 2015 Mar 23.

PMID:
25798752
34.

Amphiregulin activates human hepatic stellate cells and is upregulated in non alcoholic steatohepatitis.

McKee C, Sigala B, Soeda J, Mouralidarane A, Morgan M, Mazzoccoli G, Rappa F, Cappello F, Cabibi D, Pazienza V, Selden C, Roskams T, Vinciguerra M, Oben JA.

Sci Rep. 2015 Mar 6;5:8812. doi: 10.1038/srep08812.

35.

Histone variants and lipid metabolism.

Borghesan M, Mazzoccoli G, Sheedfar F, Oben J, Pazienza V, Vinciguerra M.

Biochem Soc Trans. 2014 Oct;42(5):1409-13. doi: 10.1042/BST20140119. Review.

PMID:
25233423
36.

Modeling interactions between Human Equilibrative Nucleoside Transporter-1 and other factors involved in the response to gemcitabine treatment to predict clinical outcomes in pancreatic ductal adenocarcinoma patients.

Tavano F, Fontana A, Pellegrini F, Burbaci FP, Rappa F, Cappello F, Copetti M, Maiello E, Lombardi L, Graziano P, Vinciguerra M, di Mola FF, di Sebastiano P, Andriulli A, Pazienza V.

J Transl Med. 2014 Sep 10;12:248. doi: 10.1186/s12967-014-0248-4.

37.

The TRPA1 channel is a cardiac target of mIGF-1/SIRT1 signaling.

Pazienza V, Pomara C, Cappello F, Calogero R, Carrara M, Mazzoccoli G, Vinciguerra M.

Am J Physiol Heart Circ Physiol. 2014 Oct 1;307(7):H939-44. doi: 10.1152/ajpheart.00150.2014. Epub 2014 Aug 8.

38.

Targeting human equilibrative nucleoside analog transporter (hENT1) expression through modified low glycemic index diet in pancreatic cancer.

Pazienza V, Del Nobile Matteo A.

Biomed Pharmacother. 2014 Jun;68(5):663-4. doi: 10.1016/j.biopha.2014.04.009. Epub 2014 May 2.

PMID:
24874245
39.

Genetic ablation of macrohistone H2A1 leads to increased leanness, glucose tolerance and energy expenditure in mice fed a high-fat diet.

Sheedfar F, Vermeer M, Pazienza V, Villarroya J, Rappa F, Cappello F, Mazzoccoli G, Villarroya F, van der Molen H, Hofker MH, Koonen DP, Vinciguerra M.

Int J Obes (Lond). 2015 Feb;39(2):331-8. doi: 10.1038/ijo.2014.91. Epub 2014 May 21.

PMID:
24849394
40.

Epithelial-mesenchymal transition: molecular pathways of hepatitis viruses-induced hepatocellular carcinoma progression.

Panebianco C, Saracino C, Pazienza V.

Tumour Biol. 2014 Aug;35(8):7307-15. doi: 10.1007/s13277-014-2075-x. Epub 2014 May 16. Review.

PMID:
24833096
41.

Non-alcoholic fatty pancreas disease pathogenesis: a role for developmental programming and altered circadian rhythms.

Carter R, Mouralidarane A, Soeda J, Ray S, Pombo J, Saraswati R, Novelli M, Fusai G, Rappa F, Saracino C, Pazienza V, Poston L, Taylor PD, Vinciguerra M, Oben JA.

PLoS One. 2014 Mar 21;9(3):e89505. doi: 10.1371/journal.pone.0089505. eCollection 2014.

42.

Hepatitis C virus, mitochondria and auto/mitophagy: exploiting a host defense mechanism.

Ruggieri V, Mazzoccoli C, Pazienza V, Andriulli A, Capitanio N, Piccoli C.

World J Gastroenterol. 2014 Mar 14;20(10):2624-33. doi: 10.3748/wjg.v20.i10.2624. Review.

43.

SIRT1-metabolite binding histone macroH2A1.1 protects hepatocytes against lipid accumulation.

Pazienza V, Borghesan M, Mazza T, Sheedfar F, Panebianco C, Williams R, Mazzoccoli G, Andriulli A, Nakanishi T, Vinciguerra M.

Aging (Albany NY). 2014 Jan;6(1):35-47.

44.

Exploitation of host clock gene machinery by hepatitis viruses B and C.

Vinciguerra M, Mazzoccoli G, Piccoli C, Tataranni T, Andriulli A, Pazienza V.

World J Gastroenterol. 2013 Dec 21;19(47):8902-9. doi: 10.3748/wjg.v19.i47.8902. Review.

45.

Identification and functional characterization of three NoLS (nucleolar localisation signals) mutations of the CDC73 gene.

Pazienza V, la Torre A, Baorda F, Alfarano M, Chetta M, Muscarella LA, Battista C, Copetti M, Kotzot D, Kapelari K, Al-Abdulrazzaq D, Perlman K, Sochett E, Cole DE, Pellegrini F, Canaff L, Hendy GN, D'Agruma L, Zelante L, Carella M, Scillitani A, Guarnieri V.

PLoS One. 2013 Dec 5;8(12):e82292. doi: 10.1371/journal.pone.0082292. eCollection 2013.

46.

Circadian transcriptome analysis in human fibroblasts from Hunter syndrome and impact of iduronate-2-sulfatase treatment.

Mazzoccoli G, Tomanin R, Mazza T, D'Avanzo F, Salvalaio M, Rigon L, Zanetti A, Pazienza V, Francavilla M, Giuliani F, Vinciguerra M, Scarpa M.

BMC Med Genomics. 2013 Oct 2;6:37. doi: 10.1186/1755-8794-6-37.

47.

Sympathetic nervous system catecholamines and neuropeptide Y neurotransmitters are upregulated in human NAFLD and modulate the fibrogenic function of hepatic stellate cells.

Sigala B, McKee C, Soeda J, Pazienza V, Morgan M, Lin CI, Selden C, Vander Borght S, Mazzoccoli G, Roskams T, Vinciguerra M, Oben JA.

PLoS One. 2013 Sep 3;8(9):e72928. doi: 10.1371/journal.pone.0072928. eCollection 2013.

48.

Affinity analysis of differentially expressed genes in hepatocytes expressing HCV core genotype 1b or 3a.

Mazza T, Castellana S, Andriulli A, Auffray C, Vinciguerra M, Pazienza V.

Biosystems. 2013 Oct;114(1):64-8. doi: 10.1016/j.biosystems.2013.05.009. Epub 2013 Jun 3.

PMID:
23743338
49.

Advance in molecular diagnostic tools for hepatitis B virus detection.

Pazienza V, Niro GA, Fontana R, Vinciguerra M, Andriulli A.

Clin Chem Lab Med. 2013 Sep;51(9):1707-17. doi: 10.1515/cclm-2013-0136. Review.

PMID:
23612658
50.

Mutual antagonism between circadian protein period 2 and hepatitis C virus replication in hepatocytes.

Benegiamo G, Mazzoccoli G, Cappello F, Rappa F, Scibetta N, Oben J, Greco A, Williams R, Andriulli A, Vinciguerra M, Pazienza V.

PLoS One. 2013 Apr 8;8(4):e60527. doi: 10.1371/journal.pone.0060527. Print 2013.

Supplemental Content

Loading ...
Support Center